 Our study demonstrates that a computational approach can predict beneficial mutations which may lead to an improved drug candidate for AD in the future.
<clarity>  Our study demonstrates that a computational approach can predict beneficial mutations which may lead to an improved drug candidate for AD in the future.
 Our study demonstrates that a computational approach may lead to an improved drug candidate for AD in the future.